Third Harmonic Bio, Inc. Quarterly General and Administrative Expense in USD from Q3 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Summary
Third Harmonic Bio, Inc. quarterly/annual General and Administrative Expense history and growth rate from Q3 2021 to Q3 2024.
  • Third Harmonic Bio, Inc. General and Administrative Expense for the quarter ending September 30, 2024 was $5.73M, a 17.5% increase year-over-year.
  • Third Harmonic Bio, Inc. General and Administrative Expense for the twelve months ending September 30, 2024 was $21M, a 5.87% increase year-over-year.
  • Third Harmonic Bio, Inc. annual General and Administrative Expense for 2023 was $20M, a 50.3% increase from 2022.
  • Third Harmonic Bio, Inc. annual General and Administrative Expense for 2022 was $13.3M, a 309% increase from 2021.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $21M $5.73M +$852K +17.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $20.1M $5.68M +$302K +5.62% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $19.8M $5.06M -$187K -3.56% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $20M $4.49M +$194K +4.52% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 $19.8M $4.88M +$1.05M +27.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $18.7M $5.37M +$1.77M +49.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $17M $5.25M +$3.68M +233% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $13.3M $4.29M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 $3.83M +$3.05M +391% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $3.6M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $1.58M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 $780K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.